CorMedix, Inc. (CRMD)
8.38
+0.12
(+1.45%)
USD |
NASDAQ |
Sep 01, 11:12
CorMedix Cash from Operations (TTM) : 253.62M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 253.62M |
| March 31, 2026 | 197.56M |
| December 31, 2025 | 175.05M |
| September 30, 2025 | 74.97M |
| June 30, 2025 | 30.46M |
| March 31, 2025 | -13.57M |
| December 31, 2024 | -50.61M |
| September 30, 2024 | -55.75M |
| June 30, 2024 | -50.79M |
| March 31, 2024 | -45.33M |
| December 31, 2023 | -38.41M |
| September 30, 2023 | -33.82M |
| June 30, 2023 | -31.12M |
| March 31, 2023 | -28.01M |
| December 31, 2022 | -24.36M |
| September 30, 2022 | -24.07M |
| June 30, 2022 | -23.58M |
| March 31, 2022 | -21.21M |
| December 31, 2021 | -21.16M |
| September 30, 2021 | -21.22M |
| June 30, 2021 | -23.03M |
| March 31, 2021 | -20.69M |
| December 31, 2020 | -21.97M |
| September 30, 2020 | -20.15M |
| June 30, 2020 | -16.80M |
| Date | Value |
|---|---|
| March 31, 2020 | -15.88M |
| December 31, 2019 | -15.28M |
| September 30, 2019 | -18.37M |
| June 30, 2019 | -19.51M |
| March 31, 2019 | -24.01M |
| December 31, 2018 | -23.70M |
| September 30, 2018 | -23.78M |
| June 30, 2018 | -25.47M |
| March 31, 2018 | -28.88M |
| December 31, 2017 | -28.59M |
| September 30, 2017 | -27.81M |
| June 30, 2017 | -27.56M |
| March 31, 2017 | -23.57M |
| December 31, 2016 | -22.27M |
| September 30, 2016 | -19.40M |
| June 30, 2016 | -15.76M |
| March 31, 2016 | -15.59M |
| December 31, 2015 | -12.36M |
| September 30, 2015 | -10.29M |
| June 30, 2015 | -9.198M |
| March 31, 2015 | -7.328M |
| December 31, 2014 | -6.541M |
| September 30, 2014 | -5.828M |
| June 30, 2014 | -5.537M |
| March 31, 2014 | -4.367M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Innoviva, Inc. | 191.49M |
| Zevra Therapeutics, Inc. | 33.40M |
| Filana Therapeutics, Inc. | -28.70M |
| Eloxx Pharmaceuticals, Inc. | -- |
| Cannabis Global, Inc. | -0.2899M |